Pfizer Inc. — Cash Flow Charts
73 quarters of history · ending 2026-03-29 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow↑+12.0% +$280M
$2.62B
Free Cash Flow↑+23.0% +$408M
$2.18B
Investing Cash Flow↓-76.0% -$2.49B
$785M
Financing Cash Flow↑+45.4% +$2.37B
$-2.86B
Capex↓-22.7% -$128M
$436M
Acquisitions
$6.93B
Stock Buybacks
$0
Stock-Based Comp↑+60.0% +$102M
$272M
Debt Issued
$5.99B
Debt Repaid
$3.01B
D&A↓-0.3% -$5M
$1.61B
Δ Working Capital↓-9.7% -$187M
$1.73B
SBC Allocated Expense↑+60.0% +$102M
$272M
SBC Granted (Grant-Date FV)NEW
$779M
SBC Vested (Vest-Date FV)NEW↓-33.2% -$214M
$431M